Survival following alcohol septal ablation or septal myectomy for patients with obstructive hypertrophic cardiomyopathy Dec. 19, 2022 Overview Show transcript Overview Juan A. Crestanello, M.D., is a cardiovascular surgeon and department chair of Cardiovascular Surgery at Mayo Clinic in Rochester, Minnesota. Dr. Crestanello, who specializes in surgery for valvular heart disease, discusses survival following alcohol septal ablation or septal myectomy for patients with obstructive hypertrophic cardiomyopathy. Receive Mayo Clinic news in your inbox. Sign up Related ContentVideoEarly septal reduction therapy for patients with obstructive hypertrophic cardiomyopathyArticleMayo Clinic Cardiovascular Surgery's specialized and technical approach to mitral valve surgery repairArticleAchieving successful outcomes with mitral valve repair for degenerative mitral regurgitation in patients with obstructive HCM undergoing myectomy VID-20544818 Medical Professionals Survival following alcohol septal ablation or septal myectomy for patients with obstructive hypertrophic cardiomyopathy